16-Jan-2026
No headlines found.
ALT5 Sigma Corporation Restores Compliance with Nasdaq Periodic Filing Requirements
Business Wire (Wed, 14-Jan 8:00 AM ET)
ALT5 Sigma Corporation Reports Q3 2025 Financial Results and Significant Milestones
Business Wire (Mon, 12-Jan 8:23 AM ET)
ALT5 Sigma Corp. Reports Company Record Annual Transaction Volume of $3.4 Billion in 2025
Business Wire (Thu, 8-Jan 8:00 AM ET)
Business Wire (Mon, 5-Jan 8:00 AM ET)
PRNewswire (Tue, 30-Dec 9:30 AM ET)
Business Wire (Tue, 30-Dec 8:30 AM ET)
ALT5 Sigma Corporation Issues Stockholder Letter From CEO Tony Isaac
Business Wire (Thu, 18-Dec 8:00 AM ET)
PRNewswire (Thu, 11-Dec 9:30 AM ET)
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Alt5 Sigma trades on the NASDAQ stock market under the symbol ALTS.
As of January 16, 2026, ALTS stock price climbed to $2.59 with 5,598,447 million shares trading.
ALTS has a beta of 0.10, meaning it tends to be less sensitive to market movements. ALTS has a correlation of 0.00 to the broad based SPY ETF.
ALTS has a market cap of $326.86 million. This is considered a Small Cap stock.
Last quarter Alt5 Sigma reported $6 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $478,000 and missed earnings estimates by -$.17.
The top ETF exchange traded funds that ALTS belongs to (by Net Assets): VTI, SCHA, VXF, ITOT, IWC.
ALTS has underperformed the market in the last year with a return of -56.5%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALTS shares. However, ALTS has outperformed the market in the last 3 month and 2 week periods, returning +18.3% and +114.0%, while SPY returned +5.0% and +1.2%, respectively. This indicates ALTS has been having a stronger performance recently.
ALTS support price is $2.22 and resistance is $2.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALTS shares will trade within this expected range on the day.
